Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernest H Choy

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Pain Management|June 18, 2016
Current treatments to counter sleep dysfunction as a pathogenic stimulus of fibromyalgiaErnest H Choy
Rheumatology (Oxford, England)|April 16, 2019
Using biologics safelyErnest H Choy
Rheumatology (Oxford, England)|January 31, 2019
Clinical significance of Janus Kinase inhibitor selectivityErnest H Choy
Rheumatology (Oxford, England)|November 5, 2019
Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritisErnest H Choy
Rheumatology (Oxford, England)|December 4, 2018
Clinical significance of Janus Kinase inhibitor selectivityErnest H Choy
Rheumatology (Oxford, England)|November 5, 2019
Fatigue in rheumatoid arthritisErnest H Choy, Emma Dures
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
The role of interleukin 6 in the pathophysiology of rheumatoid arthritisSrinivasan Srirangan, Ernest H Choy
Rheumatology (Oxford, England)|May 11, 2021
Rheumatologists at a crossroads: blocking tumour necrosis factor or interleukin 6 in disease-modifying anti-rheumatic drug inadequate responder patients with rheumatoid arthritisLuca Quartuccio, Ernest H Choy
Seminars in Arthritis and Rheumatism|January 1, 2021
C-reactive protein and implications in rheumatoid arthritis and associated comorbiditiesJanet E Pope, Ernest H Choy
Rheumatic Diseases Clinics of North America|August 4, 2009
Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials)Ernest H Choy, Philip J Mease
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Pain Management|June 18, 2016
Current treatments to counter sleep dysfunction as a pathogenic stimulus of fibromyalgiaErnest H Choy
Rheumatology (Oxford, England)|April 16, 2019
Using biologics safelyErnest H Choy
Rheumatology (Oxford, England)|January 31, 2019
Clinical significance of Janus Kinase inhibitor selectivityErnest H Choy
Rheumatology (Oxford, England)|November 5, 2019
Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritisErnest H Choy
Rheumatology (Oxford, England)|December 4, 2018
Clinical significance of Janus Kinase inhibitor selectivityErnest H Choy
Rheumatology (Oxford, England)|November 5, 2019
Fatigue in rheumatoid arthritisErnest H Choy, Emma Dures
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
The role of interleukin 6 in the pathophysiology of rheumatoid arthritisSrinivasan Srirangan, Ernest H Choy
Rheumatology (Oxford, England)|May 11, 2021
Rheumatologists at a crossroads: blocking tumour necrosis factor or interleukin 6 in disease-modifying anti-rheumatic drug inadequate responder patients with rheumatoid arthritisLuca Quartuccio, Ernest H Choy
Seminars in Arthritis and Rheumatism|January 1, 2021
C-reactive protein and implications in rheumatoid arthritis and associated comorbiditiesJanet E Pope, Ernest H Choy
Rheumatic Diseases Clinics of North America|August 4, 2009
Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials)Ernest H Choy, Philip J Mease
Pageof 8